Pendal Group LTD Eli Lilly & CO Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Pendal Group LTD holds 20,089 shares of LLY stock, worth $15.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

20,089

Previous 24,428 17.76%

Holding current value

$15.9 Million

Previous $7.9 Million 6.95%

% of portfolio

0.06%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $1.4 Million - $1.63 Million	-4,339 Reduced 17.76%	20,089 $0
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $6.66 Million - $7.59 Million	22,463 Added 1143.16%	24,428 $7.9 Million
Q2 2022 Jul 25, 2022	SELL	$278.73 - $327.27 $91,423 - $107,344	-328 Reduced 14.3%	1,965 $637,000
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $2,816 - $3,499	-12 Reduced 0.52%	2,293 $657,000
Q4 2021 Jan 18, 2022	SELL	$224.85 - $279.04 $1.52 Million - $1.89 Million	-6,776 Reduced 74.62%	2,305 $637,000
Q3 2021 Nov 05, 2021	BUY	$221.6 - $272.71 $1.12 Million - $1.38 Million	5,061 Added 125.9%	9,081 $2.1 Million
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $184,341 - $238,444	1,021 Added 34.04%	4,020 $923,000
Q1 2021 May 24, 2021	BUY	$164.32 - $212.72 $492,795 - $637,947	2,999 New	2,999 $560,000
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $1.24 Million - $1.6 Million	-7,517 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$130.46 - $172.63 $365,548 - $483,709	-2,802 Reduced 27.15%	7,517 $1.27 Million
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $813,860 - $941,377	5,566 Added 117.1%	10,319 $1.53 Million
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $138,875 - $167,135	1,018 Added 27.26%	4,753 $780,000
Q1 2020 May 04, 2020	SELL	$119.05 - $147.35 $250,838 - $310,466	-2,107 Reduced 36.07%	3,735 $518,000
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $2.9 Million - $3.59 Million	-27,126 Reduced 82.28%	5,842 $767,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $5.59 Million - $6.08 Million	-52,351 Reduced 61.36%	32,968 $3.69 Million
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $8.52 Million - $9.95 Million	76,912 Added 914.86%	85,319 $0
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $5.41 Million - $6.36 Million	-48,560 Reduced 85.24%	8,407 $0
Q4 2018 Jan 30, 2019	BUY	$105.9 - $118.64 $6.03 Million - $6.76 Million	56,967 New	56,967 $6.59 Million
Q2 2018 Jul 18, 2018	SELL	$75.7 - $86.88 $55,109 - $63,248	-728 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $1.04 Million - $1.12 Million	-12,731 Reduced 94.59%	728 $0
Q3 2017 Nov 01, 2017	SELL	$77.07 - $85.54 $1.69 Million - $1.88 Million	-21,983 Reduced 62.03%	13,459 $0
Q2 2017 Aug 11, 2017	BUY	N/A	35,442	35,442 $0

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account